The AACR Special Conference in Cancer Research: Cancer Biology-Informed Radioligand Therapy, organized by the American Association for Cancer Research (AACR) in association with the Cancer Molecular Imaging and Theranostics Task Force, will take place on 7–10 January 2027 at the Hilton San Diego Bayfront in San Diego, California.

The conference will bring together experts in cancer biology, immunotherapy, radiochemistry, nuclear physics, radiation biology, and radioligand therapy to examine how systemic beta- and alpha-emitting isotopes interact with tumors, the tumor microenvironment, and the immune system. Sessions will also explore radiotheranostics, novel isotopes, repurposed radioligand therapies, and combinations with targeted therapies, cellular treatments, immunotherapy, and external-beam radiation. The abstract submission deadline is 21 October 2026 at 1:00 p.m. ET.